CEO sold ~$2.43M of Quest Diagnostics
Scheduled in advanceLoading…
Stake as of Jun 30, 2026 · Filed Aug 14, 2026
The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
Undefined
Compared with the manager's prior 13F
—
NaN
For the same quarter
CEO sold ~$2.43M of Quest Diagnostics
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.
Officer sold ~$3.89M of Quest Diagnostics
Scheduled in advance